Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis
Author:
Affiliation:
1. Department of Pulmonary, Critical Care and Sleep Medicine
2. Department of Hematology and Medical Oncology, Tisch Cancer Institute; and
3. Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
Publisher
American Thoracic Society
Subject
Pulmonary and Respiratory Medicine
Link
https://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201807-481OC
Reference72 articles.
1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
2. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
3. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
4. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
5. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening;American Journal of Respiratory and Critical Care Medicine;2024-01-15
2. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision;Respirology;2024-01-11
3. Integrative bioinformatics analysis reveals ECM and nicotine-related genes in both LUAD and LUSC, but different lung fibrosis-related genes are involved in LUAD and LUSC;Nucleosides, Nucleotides & Nucleic Acids;2024-01-10
4. Pulse versus non‐pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis;Respirology;2023-12-12
5. Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents;Functional & Integrative Genomics;2023-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3